Evaluation of Effectiveness of vitamin D on immunity of atopic dermatitis patients

Evaluation of Effectiveness of vitamin D in Treg cell frequency in atopic dermatitis and control group

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150716023235N13

Enrollment

Registered

2018-11-02

Start date

2017-09-02

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis. Other atopic dermatitis

Interventions

Intervention 1: Intervention group: For patients with atopic dermatitis, for a period of 2 months, one tablet or drops of vitamin D1000 unit was given by the combination of 1-alpha-hydroxycholecalcif

Eligibility

Sex/Gender

All

Age

1 Months to 50 Years

Inclusion criteria

Inclusion criteria: Patients up to 50 years old who have clinical signs of atopic dermatitis Low serum vitamin D levels No oral drug for controlling atopic dermatitis recently

Exclusion criteria

Exclusion criteria: Patients with other atopic diseases Having skin infections

Design outcomes

Primary

Measure	Time frame
Clinical symptoms of atopic dermatitis. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the consumption. Method of measurement: SCORAD questionnaire.;Frequency of T reg cells in the blood. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the consumption. Method of measurement: Flowcytometry.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPayam Payandeh

Mashhad University of Medical Sciences

dr.payandeh@gmail.com+98 51 3801 2770

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026